The forecast for malignant neoplasms mortality in Brazil indicates a gradual increase from 2024 to 2028, with figures rising from 109.1 to 110.2 deaths per hundred thousand persons. Compared to the data in 2023, this upward trend signals an annual increase. The year-on-year percentage increase remains steady at approximately 0.27%, reflecting a minor yet persistent rise in mortality rates. Over the five-year period ending in 2028, the compound annual growth rate (CAGR) is expected to be around 0.20%, underscoring a consistent, albeit slow, growth in mortality rates due to malignant neoplasms.
Future trends to watch include advancements in cancer treatments and prevention methods, government healthcare policies, and public health campaigns that could impact mortality rates. Additionally, changes in lifestyle factors and environmental influences might alter this forecast. Monitoring these variables will be crucial to understanding and mitigating future mortality risks related to malignant neoplasms in Brazil.
